Steroid or tacrolimus withdrawal in renal transplant recipients using sirolimus
✍ Scribed by Tainá Veras de Sandes Freitas; Kelly Miyuki Harada; Cláudia Rosso Felipe; Nelson Zocoler Galante; Edison Luiz Mandia Sampaio; Edson Ikehara; Fernando Alfieri; Hélio Tedesco-Silva Júnior; José Osmar Medina-Pestana
- Publisher
- Springer Netherlands
- Year
- 2011
- Tongue
- English
- Weight
- 185 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0301-1623
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Exercise capacity increases significantly soon after transplantation; however, over time it does not further improve and patients remain low compared to normal levels. the limitations to exercise following transplantation have not been identified, but may be related to immunosuppress
Sirolimus is used in patients with renal insufficiency after liver transplantation (LT) and especially in those with calcineurin inhibitor (CNI)-associated nephrotoxicity. We conducted a systematic review of all randomized controlled trials and observational studies to test the hypothesis that the u
Induction therapy with T-cell depleting drugs in liver transplantation is controversial. This study examined the use of rabbit antithymocyte globulin (RATG) with delayed introduction of tacrolimus in liver transplant recipients. Additional subgroup analysis compared patients with or without hepatiti